Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421.
Cancer treatment and research communications·2019
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
SAA1 Promotes Pro-inflammatory Macrophage-mediated Bone Invasion in Silent Corticotroph Adenomas.
Genomics, proteomics & bioinformatics·2026
Comparison of rat hypertrophic scar models: Caudal tension model with superior pathological consistency.
Animal models and experimental medicine·2026